KMVAX logo

Kirr Marbach Partners Value Fund (KMVAX)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Kirr Marbach Partners Value Fund (KMVAX) with AI Score 44/100 (Weak). Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm focused on investing in common stocks across various market capitalizations. Market cap: 0, Sector: Financial services.

Last analyzed: Mar 18, 2026
Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm focused on investing in common stocks across various market capitalizations. The fund aims to achieve its investment objective by strategically allocating its assets to companies with small, medium, and large market capitalizations.
44/100 AI Score

Kirr Marbach Partners Value Fund (KMVAX) Financial Services Profile

HeadquartersColumbus, US
IPO Year1998

Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm that invests in common stocks across small, medium, and large-capitalization companies, seeking to maximize returns through strategic asset allocation. The fund maintains a diversified portfolio with at least 65% of its assets in equity securities, operating within the competitive financial services sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 18, 2026

Investment Thesis

Kirr Marbach Partners Value Fund (KMVAX) presents a notable research candidate due to its diversified investment approach and focus on value investing. The fund's strategy of allocating assets across small, medium, and large-cap companies allows it to capture growth opportunities across various market segments. With at least 65% of its assets invested in equity securities, KMVAX is positioned to benefit from potential market appreciation. However, the fund's performance is subject to market volatility and economic conditions. The fund's beta of 1.08 indicates that it is slightly more volatile than the market. The absence of a dividend yield may deter income-seeking investors. The fund's success hinges on its ability to identify and capitalize on undervalued investment opportunities, while effectively managing risk.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.11 billion indicates a relatively small fund within the asset management industry.
  • Beta of 1.08 suggests the fund's volatility is slightly higher than the overall market.
  • Investment strategy focuses on common stocks of companies with small, medium, and large market capitalizations.
  • At least 65% of total assets are allocated to common stocks or other equity securities, emphasizing equity-focused investment.
  • Absence of dividend yield may be a drawback for income-focused investors.

Competitors & Peers

Strengths

  • Diversified investment approach across market capitalizations.
  • Experienced investment team with a focus on value investing.
  • Disciplined investment process with rigorous research and due diligence.
  • Commitment to long-term capital appreciation.

Weaknesses

  • Relatively small market capitalization compared to larger asset managers.
  • Absence of dividend yield may deter income-seeking investors.
  • Performance is subject to market volatility and economic conditions.
  • High beta compared to benchmark.

Catalysts

  • Upcoming: Potential for increased investor inflows due to strong market performance in equity markets.
  • Ongoing: Strategic asset allocation across diverse market capitalizations to capture growth opportunities.
  • Ongoing: Focus on value investing to identify undervalued companies with long-term potential.

Risks

  • Potential: Market volatility and economic downturns could negatively impact fund performance.
  • Potential: Increased competition from other asset management firms could lead to lower fees and margins.
  • Potential: Regulatory changes and compliance requirements could increase operating costs.
  • Ongoing: Dependence on the investment team's ability to identify and capitalize on attractive investment opportunities.

Growth Opportunities

  • Expansion into new asset classes: KMVAX could explore opportunities to expand its investment offerings into alternative asset classes such as private equity, real estate, or infrastructure. These asset classes can provide diversification benefits and potentially higher returns, attracting a broader range of investors. The market for alternative assets is projected to reach $17.2 trillion by 2025, presenting a significant growth opportunity for KMVAX. Timeline: 2-3 years.
  • Enhancing digital marketing and investor relations: KMVAX can leverage digital marketing channels and enhance its investor relations efforts to attract new investors and retain existing clients. By improving its online presence and providing transparent communication, KMVAX can build trust and credibility with investors. The digital asset management market is expected to grow at a CAGR of 20% over the next five years, highlighting the importance of digital engagement. Timeline: 1 year.
  • Strategic partnerships and acquisitions: KMVAX could pursue strategic partnerships or acquisitions to expand its market reach and enhance its investment capabilities. By collaborating with other asset management firms or acquiring complementary businesses, KMVAX can gain access to new markets, technologies, and talent. The asset management industry is undergoing consolidation, creating opportunities for strategic alliances and acquisitions. Timeline: 3-5 years.
  • Focus on sustainable and responsible investing: KMVAX can capitalize on the growing demand for sustainable and responsible investing by incorporating environmental, social, and governance (ESG) factors into its investment process. By offering ESG-focused investment products, KMVAX can attract socially conscious investors and align its investment strategy with global sustainability trends. The ESG investing market is projected to reach $50 trillion by 2025, indicating a significant growth opportunity. Timeline: 2 years.
  • Developing customized investment solutions: KMVAX can differentiate itself by offering customized investment solutions tailored to the specific needs and objectives of individual investors. By providing personalized investment advice and portfolio management services, KMVAX can build stronger relationships with clients and attract high-net-worth individuals. The demand for customized investment solutions is increasing as investors seek more control and flexibility over their portfolios. Timeline: Ongoing.

Opportunities

  • Expansion into new asset classes, such as alternative investments.
  • Enhancing digital marketing and investor relations efforts.
  • Strategic partnerships and acquisitions to expand market reach.
  • Focus on sustainable and responsible investing (ESG) to attract socially conscious investors.

Threats

  • Increased competition from other asset management firms.
  • Regulatory changes and compliance requirements.
  • Economic downturns and market volatility.
  • Changing investor preferences and demand for passive investment strategies.

Competitive Advantages

  • Experienced investment team with a proven track record.
  • Disciplined investment process focused on value investing.
  • Diversified portfolio across market capitalizations and sectors.

About KMVAX

Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm dedicated to delivering value through strategic investments in common stocks. The fund's primary objective is to achieve long-term capital appreciation by investing in companies across the market capitalization spectrum, including small-cap (less than $1 billion), mid-cap ($1-$15 billion), and large-cap (more than $15 billion) enterprises. The fund operates under the principle of diversification, ensuring that at least 65% of its total assets are allocated to common stocks or other equity securities. KMVAX's investment strategy involves a rigorous analysis of potential investments, focusing on companies with strong fundamentals and growth potential. The fund's portfolio construction process emphasizes a balance between risk and return, aiming to generate consistent performance over time. The fund's investment decisions are guided by a team of experienced professionals who conduct in-depth research and due diligence to identify attractive investment opportunities. KMVAX competes within the broader asset management industry, facing competition from other mutual funds, hedge funds, and investment advisory firms. The fund differentiates itself through its focus on value investing and its commitment to a diversified portfolio. As of 2026, Kirr Marbach Partners Value Fund manages approximately $0.11 billion in assets.

What They Do

  • Invests in common stocks of companies with small-capitalizations (less than $1 billion).
  • Invests in common stocks of companies with medium-capitalizations ($1-$15 billion).
  • Invests in common stocks of companies with large-capitalizations (more than $15 billion).
  • Allocates at least 65% of its total assets to common stocks or other equity securities.
  • Seeks long-term capital appreciation through strategic asset allocation.
  • Conducts in-depth research and due diligence to identify attractive investment opportunities.
  • Manages a diversified portfolio to balance risk and return.

Business Model

  • Generates revenue through management fees charged on assets under management (AUM).
  • AUM is influenced by investment performance and investor inflows/outflows.
  • Expenses include investment management fees, administrative costs, and marketing expenses.

Industry Context

Kirr Marbach Partners Value Fund (KMVAX) operates within the asset management industry, a sector characterized by intense competition and evolving market dynamics. The industry is influenced by factors such as interest rates, economic growth, and investor sentiment. Asset management firms compete for investor capital by offering a range of investment products and services, including mutual funds, exchange-traded funds (ETFs), and separately managed accounts. The industry is subject to regulatory oversight and compliance requirements, which can impact profitability and growth. KMVAX competes with firms like AABPX, DDDAX, EAERX, GPRIX, and IHD, each vying for market share and investor assets.

Key Customers

  • Individual investors seeking long-term capital appreciation.
  • Institutional investors, including pension funds, endowments, and foundations.
  • Financial advisors and wealth managers seeking investment solutions for their clients.
AI Confidence: 81% Updated: Mar 18, 2026

Financials

Chart & Info

Kirr Marbach Partners Value Fund (KMVAX) stock price: Price data unavailable

Latest News

No recent news available for KMVAX.

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KMVAX.

Price Targets

Wall Street price target analysis for KMVAX.

MoonshotScore

44/100

What does this score mean?

The MoonshotScore rates KMVAX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

What Investors Ask About Kirr Marbach Partners Value Fund (KMVAX)

What does Kirr Marbach Partners Value Fund do?

Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm that invests in common stocks across various market capitalizations, including small-cap (less than $1 billion), mid-cap ($1-$15 billion), and large-cap (more than $15 billion) companies. The fund's primary objective is to achieve long-term capital appreciation by strategically allocating its assets to companies with strong fundamentals and growth potential. KMVAX operates under the principle of diversification, ensuring that at least 65% of its total assets are allocated to common stocks or other equity securities, aiming to deliver consistent performance over time.

What do analysts say about KMVAX stock?

AI analysis is pending for KMVAX, so there is no current analyst consensus available. Key valuation metrics to consider would include the fund's expense ratio, historical performance relative to its benchmark, and its risk-adjusted returns. Growth considerations would focus on the fund's ability to attract new assets under management (AUM) and its success in identifying and capitalizing on undervalued investment opportunities. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions.

What are the main risks for KMVAX?

The main risks for Kirr Marbach Partners Value Fund (KMVAX) include market volatility, which can significantly impact the fund's performance, especially given its focus on equity securities. Economic downturns and rising interest rates could also negatively affect the value of the fund's investments. Additionally, increased competition from other asset management firms could lead to lower fees and margins. Regulatory changes and compliance requirements pose ongoing challenges, potentially increasing operating costs and impacting profitability. The fund's success also depends on the investment team's ability to identify and capitalize on attractive investment opportunities, which is subject to inherent uncertainty.

What is Kirr Marbach Partners Value Fund's credit quality and risk management approach?

As Kirr Marbach Partners Value Fund primarily invests in common stocks, credit quality is not a direct concern in the same way it would be for a fixed-income fund. However, the fund's risk management approach involves diversification across market capitalizations and sectors to mitigate potential losses from individual stock holdings. The fund's investment team conducts thorough research and due diligence to assess the financial health and stability of the companies in which it invests. The fund's beta of 1.08 suggests a slightly higher volatility than the market, indicating a moderate risk profile.

What regulatory challenges does Kirr Marbach Partners Value Fund face?

Kirr Marbach Partners Value Fund operates within a highly regulated environment, subject to oversight by the Securities and Exchange Commission (SEC) and other regulatory bodies. The fund must comply with various regulations, including the Investment Company Act of 1940 and the Dodd-Frank Act, which govern fund operations, disclosure requirements, and investor protection. Compliance costs can be significant, requiring ongoing investment in personnel, technology, and legal expertise. Changes in regulations, such as those related to fund fees, transparency, or investment restrictions, could impact the fund's profitability and competitiveness.

What are the key factors to evaluate for KMVAX?

Kirr Marbach Partners Value Fund (KMVAX) currently holds an AI score of 44/100, indicating low score. Key strength: Diversified investment approach across market capitalizations.. Primary risk to monitor: Potential: Market volatility and economic downturns could negatively impact fund performance.. This is not financial advice.

How frequently does KMVAX data refresh on this page?

KMVAX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven KMVAX's recent stock price performance?

Recent price movement in Kirr Marbach Partners Value Fund (KMVAX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified investment approach across market capitalizations.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • AI analysis pending for KMVAX, limiting the depth of financial insights.
  • Information is based on available data as of 2026-03-18.
Data Sources

Popular Stocks